What is Vor Biopharma's R&D?

Vor Biopharma (VOR) reported R&D of $17.6M in Q1 2026.

How has Vor Biopharma's R&D changed year-over-year?

Vor Biopharma's R&D decreased by 34.1% year-over-year, from $26.7M to $17.6M.

What is the long-term trend for Vor Biopharma's R&D?

Over 4 years (2021 to 2025), Vor Biopharma's R&D has grown at a 61.3% compound annual growth rate (CAGR), from $47.53M to $321.53M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Vor Biopharma VOR R&D

R&D at other companies

AmgenAMGN

$1.72B+15.7%

Dianthus TherapeuticsDNTH

$34.53M+27.9%

Cullinan Therapeutics, Inc.CGEM

$42.12M+1.6%

Design Therapeutics, Inc.DSGN

$14.38M-6.5%

Avalo TherapeuticsAVTX

$14.05M+54.0%

Nektar TherapeuticsNKTR

$35.68M+17.1%

Other financials

Income statement

See full

Operating income-$35.2M-5.6%

Net income-$219.6M-576%

EPS (diluted)-$5.11+1.9%

Balance sheet

See full

Cash & equivalents$169.9M+239%

Total debt$2.9M-90.5%

Total equity-$150.4M-328%

Total assets$506.7M+364%

Cash flow

See full

Operating cash flow-$38.2M-23.1%

CapEx$48.0K-79.2%

Free cash flow-$38.3M-22.4%

Valuation

See full

Market cap$784.61M+2,513%

Enterprise value$617.68M+5,639%

Returns & leverage

See full

Return on equity-125.4%+671pp

Debt / equity0.5×+0.2×

Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vor Biopharma's R&D?: Vor Biopharma (VOR) reported R&D of $17.6M in Q1 2026.
How has Vor Biopharma's R&D changed year-over-year?: Vor Biopharma's R&D decreased by 34.1% year-over-year, from $26.7M to $17.6M.
What is the long-term trend for Vor Biopharma's R&D?: Over 4 years (2021 to 2025), Vor Biopharma's R&D has grown at a 61.3% compound annual growth rate (CAGR), from $47.53M to $321.53M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.